Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for iRhythm Technologies (IRTC : NSDQ)
 
 • Company Description   
iRhythm Technologies, Inc. is a digital healthcare company. It focuses on the provision of ambulatory electrocardiogram, monitoring for patients at risk for arrhythmias primarily in the United States. The company offers ZIO Service, a platform which provides wearable biosensor with cloud-based data analytics that distill data from heartbeats into clinically actionable information. iRhythm Technologies, Inc. is headquartered in San Francisco, California.

Number of Employees: 2,000

 
 • Price / Volume Information   
Yesterday's Closing Price: $177.44 Daily Weekly Monthly
20 Day Moving Average: 376,172 shares
Shares Outstanding: 32.22 (millions)
Market Capitalization: $5,716.96 (millions)
Beta: 1.12
52 Week High: $212.00
52 Week Low: $86.99
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -2.16% -1.99%
12 Week 0.50% -1.12%
Year To Date 0.00% 0.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
699 8th Street Suite 600
-
San Francisco,CA 94103
USA
ph: 415-632-5700
fax: -
investors@irhythmtech.com http://www.irhythmtech.com
 
 • General Corporate Information   
Officers
Quentin S. Blackford - President and Chief Executive Officer
Abhijit Y. Talwalkar - Chairman
Daniel Wilson - Chief Financial Officer
Marc Rosenbaum - Chief Accounting Officer
Bruce G. Bodaken - Director

Peer Information
iRhythm Technologies (HLIS)
iRhythm Technologies (AZTA)
iRhythm Technologies (APYI)
iRhythm Technologies (RNVA)
iRhythm Technologies (HMSY)
iRhythm Technologies (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 450056106
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/25
Next Expected EPS Date: 02/19/26
Share - Related Items
Shares Outstanding: 32.22
Most Recent Split Date: (:1)
Beta: 1.12
Market Capitalization: $5,716.96 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.46 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.45 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 6.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: 34.02% Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/19/26  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 46.90
Price/Cash Flow: -
Price / Sales: 8.14
EPS Growth
vs. Year Ago Period: 95.24%
vs. Previous Quarter: 81.25%
Sales Growth
vs. Year Ago Period: 30.74%
vs. Previous Quarter: 3.32%
ROE
12/31/25 - -
09/30/25 - -41.86
06/30/25 - -90.03
ROA
12/31/25 - -
09/30/25 - -4.42
06/30/25 - -8.52
Current Ratio
12/31/25 - -
09/30/25 - 4.63
06/30/25 - 5.02
Quick Ratio
12/31/25 - -
09/30/25 - 4.50
06/30/25 - 4.88
Operating Margin
12/31/25 - -
09/30/25 - -6.00
06/30/25 - -12.09
Net Margin
12/31/25 - -
09/30/25 - -7.32
06/30/25 - -14.06
Pre-Tax Margin
12/31/25 - -
09/30/25 - -7.23
06/30/25 - -13.94
Book Value
12/31/25 - -
09/30/25 - 3.78
06/30/25 - 3.23
Inventory Turnover
12/31/25 - -
09/30/25 - 12.56
06/30/25 - 12.85
Debt-to-Equity
12/31/25 - -
09/30/25 - 5.32
06/30/25 - 6.25
Debt-to-Capital
12/31/25 - -
09/30/25 - 84.18
06/30/25 - 86.21
 

Powered by Zacks Investment Research ©